NIH Technology Transfer

As of March 11, 2026, this account is no longer active.
Please look for our content on the National Institutes of Health (NIH) page and follow along for the latest news and information from NIH! For NIH Tech Transfer specific news and technology opportunities, please visit our website at techtransfer.nih.gov.

NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases' Dr. John O’Shea has been selected as a National Academy of Inventors Fellow. Dr. O’Shea is a leading inventor in the field of cytokine signal transduction, specifically in dissecting the role of the Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) family transcription in immunoregulation. There are now 11 approved JAK inhibitors for multiple forms of arthritis, inflammatory bowel disease, dermatologic disorders, and COVID-19.

The National Academy of Inventors honors individuals as Fellows to recognize that not only are they phenomenal researchers holding prestigious honors and distinctions but are also incredible inventors.

You can read more about Dr. O’Shea’s work and the other NIH inventor selected as an NAI Fellow this year on our website: go.nih.gov/dKup1at

Two NIH Inventors Selected as 2025 National Academy of Inventors Fellows | Technology Transfer These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

In honor of Tech Transfer Professionals Day, we wanted to reshare IAM's recognition of NIH OTT Director Tara Kirby. You can read about the deal that secured her spot on the list of one of the most innovative and influential dealmakers of the year below.

www.techtransfer.nih.gov